Despite the ongoing development of treatment standards for asthma, many patients who suffer from this chronic disease do not
receive optimal care. The emphasis of asthma treatment is to achieve control through an understanding of the pathophysiology
and pharmacotherapy of this chronic condition. Leukotriene receptor antagonists are a class of drugs which act as controllers by
exhibiting anti-inflammatory action. Updated treatment guidelines place emphasis on the use of anti-inflammatory medication as
the foundation of asthma treatment. Therefore, leukotriene receptor antagonists have been positioned as maintenance treatment for
adults and children with chronic asthma.